Adaptive Medical Weight Management

Adaptive Medical Weight Management operates as a telehealth-focused clinic serving patients across Texas, Florida, and Hawaii, with lead provider Allison Arnett, RN, FNP-BC, bringing specialized training from the Obesity Medicine Association to her practice. Based in Dallas, TX, the clinic structures its approach around evidence-based GLP-1 receptor agonist protocols, offering Liraglutide, Semaglutide, and Tirzepatide as primary pharmaceutical interventions for metabolic health and weight regulation. Rather than following a one-size-fits-all model, Arnett conducts comprehensive virtual assessments that examine metabolic markers, hormone panels, and individual response patterns to determine appropriate peptide selection and dosing strategies for each patient.

The clinic's peptide therapy program centers on incretin-based medications that modulate appetite signaling and glucose metabolism. Liraglutide serves as an option for patients requiring once-daily dosing with established cardiovascular benefit data, while Semaglutide provides weekly administration with documented efficacy in clinical weight management studies. Tirzepatide, a dual GIP/GLP-1 receptor agonist, represents the clinic's option for patients who may benefit from enhanced metabolic targeting through its dual-pathway mechanism. Arnett's protocols include structured titration schedules designed to minimize gastrointestinal adaptation periods while optimizing therapeutic response, with ongoing monitoring of body composition changes, metabolic markers, and medication tolerance throughout treatment.

Allison Arnett's background as a board-certified Family Nurse Practitioner with Obesity Medicine Association certification informs the clinic's clinical framework, which integrates peptide therapy with hormone optimization strategies. Her approach involves analyzing thyroid function, cortisol patterns, and sex hormone balance as factors that influence metabolic rate and weight regulation capacity. Virtual consultations allow Arnett to review laboratory results, adjust medication protocols, and address patient questions about side effect management, dietary modifications during GLP-1 therapy, and realistic timeline expectations for metabolic changes. This telehealth model eliminates geographic barriers for patients across the three-state service area while maintaining consistent provider continuity.

Patients engaging with Adaptive Medical Weight Management begin with an initial virtual consultation where Arnett reviews medical history, current medications, previous weight management attempts, and specific health goals. Following this assessment, patients receive prescriptions through partnered pharmacies, detailed administration instructions for their prescribed peptide, and a monitoring schedule that typically includes follow-up consultations at four-week intervals during the initial treatment phase. The clinic provides guidance on managing common GLP-1 side effects such as nausea or altered appetite patterns, along with nutritional recommendations that support adequate protein intake and micronutrient status during periods of reduced caloric consumption. Patients maintain communication access for questions between scheduled appointments, creating a supported treatment environment despite the remote care delivery model.

The telehealth structure positions Adaptive Medical Weight Management as an accessible option for patients in Dallas and throughout Texas, as well as residents of Florida and Hawaii seeking specialized obesity medicine expertise without requiring in-person clinic visits. Arnett's focus on peptide-based weight management combined with hormone optimization creates a dual-pathway approach that addresses both appetite regulation and underlying endocrine factors affecting metabolism. The clinic's model serves patients who prefer the convenience of virtual care, those with scheduling constraints that make traditional office visits challenging, and individuals seeking provider expertise specifically in incretin-based therapies and metabolic health optimization.